Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piroxicam vs Articaine for Endodontic Pain in Pulpitis
NCT03612323Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Nov 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of piroxicam in pulpitis (2 arms), sponsored by Cairo University. Primary endpoint: Alleviation of post-operative pain severity at 48 hours. Status: unknown.
02
Drugs
piroxicam
03
Conditions
pulpitis
Beyond the preview
Go deeper on NCT03612323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03612323.